name:-0.012305974960327
name:-0.0066688060760498
name:-0.00046396255493164
MARSHALL EDWARDS, INC. Patent Filings

MARSHALL EDWARDS, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MARSHALL EDWARDS, INC..The latest application filed is for "isoflavonoid compounds and methods for the treatment of cancer".

Company Profile
0.6.7
  • MARSHALL EDWARDS, INC. - San Diego CA
  • MARSHALL EDWARDS, INC - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Isoflavonoid Compounds And Methods For The Treatment Of Cancer
App 20140234295 - Jeoffreys; George ;   et al.
2014-08-21
Substituted chroman derivatives, medicaments and use in therapy
Grant 8,697,891 - Heaton , et al. April 15, 2
2014-04-15
Isoflavonoid Compositions And Methods For The Treatment Of Cancer
App 20130273177 - Moreno; Ofir
2013-10-17
Chroman derivatives, medicaments and use in therapy
Grant 8,461,361 - Heaton , et al. June 11, 2
2013-06-11
Oxazinyl isoflavonoid compounds, medicaments and use
Grant 8,367,659 - Heaton , et al. February 5, 2
2013-02-05
Remission Therapy Of Cancer With Isoflavonoids
App 20120251630 - Alvero; Ayesha B. ;   et al.
2012-10-04
Chroman Derivatives, Medicaments And Use In Therapy
App 20120172424 - HEATON; Andrew ;   et al.
2012-07-05
Substituted Chroman Derivatives, Medicaments And Use In Therapy
App 20120114766 - HEATON; Andrew ;   et al.
2012-05-10
Chroman derivatives, medicaments and use in therapy
Grant 8,163,795 - Heaton , et al. April 24, 2
2012-04-24
Anti-inflammatory Modalities
App 20120059176 - WALKER; Catherine ;   et al.
2012-03-08
Chroman Derivatives, Medicaments And Use In Therapy
App 20120004296 - Heaton; Andrew ;   et al.
2012-01-05
Substituted chroman derivatives, medicaments and use in therapy
Grant 8,084,628 - Heaton , et al. December 27, 2
2011-12-27
Chroman derivatives, medicaments and use in therapy
Grant 8,080,675 - Heaton , et al. December 20, 2
2011-12-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed